Jason Coloma

Jason Coloma

Director Ejecutivo en
Maze Therapeutics, Inc.
.

Fortuna: 29 M $ al 30/09/2026

50 años
Health Technology
Consumer Services
Commercial Services

Perfil

Jason V.
Coloma
is currently President, Chief Executive Officer & Director at Maze Therapeutics, Inc. since 2019.
Dr. Coloma is also Director at St. Anthony's Foundation and Director at Braveheart Bio, Inc. starting in 2024.
Former roles include Independent Director at BioAge Labs, Inc. from 2021 to 2024; Chief Business Officer & Senior Vice President at Corvus Pharmaceuticals, Inc. from 2016 to 2017; Vice President & Global Head-Oncology Partnering at Roche Diagnostics Corp.
from 2007 to 2016; Chief Business Officer at Insitro, Inc. from 2018 to 2019; and Chief Business Officer at Celsius Therapeutics, Inc. from 2017 to 2018.
Education includes graduate and doctorate degrees from the University of California, Berkeley; an undergraduate degree from the University of San Francisco; and an MBA from the Tuck School of Business at Dartmouth.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
1,22 %
06/08/2026 1.100.456 ( 1,22 % ) 22 M $ 30/09/2026
0,42 %
01/10/2026 234.367 ( 0,42 % ) 6 M $ 30/09/2026

Cargos activos de Jason Coloma

EmpresasCargoInicio
Director Ejecutivo 01/06/2019
Director/Miembro de la Junta -

Antiguos cargos conocidos de Jason Coloma.

EmpresasCargoFin
BIOAGE LABS, INC. Director/Miembro de la Junta 20/08/2024
Corporate Officer/Principal 01/08/2019
Corporate Officer/Principal 01/11/2018
CORVUS PHARMACEUTICALS, INC. Contacto de Relaciones con Inversores 01/07/2017
Corporate Officer/Principal 01/07/2016
Ver el detalle de la experiencia de Jason Coloma.

Formación de Jason Coloma.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

68

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology